Jefferies Group LLC Acadia Pharmaceuticals Inc Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Sep 21, 2023	BUY	$13.01 - $27.22 $544,494 - $1.14 Million	41,852 Added 636.82%	48,424 $682,000
Q2 2022 Aug 15, 2022	BUY	$13.01 - $27.22 $629,996 - $1.32 Million	48,424 New	48,424 $682,000
Q2 2021 Aug 16, 2021	SELL	$19.4 - $27.42 $127,496 - $180,204	-6,572 Closed	0 $0
Q1 2021 Sep 21, 2023	SELL	$25.02 - $54.99 $480,308 - $1.06 Million	-19,197 Reduced 74.5%	6,572 $169,000
Q1 2021 May 14, 2021	SELL	$25.02 - $54.99 $480,308 - $1.06 Million	-19,197 Reduced 74.5%	6,572 $170,000
Q4 2020 Sep 21, 2023	BUY	$41.04 - $56.79 $1.06 Million - $1.46 Million	25,769 New	25,769 $1.38 Million
Q4 2020 Feb 16, 2021	BUY	$41.04 - $56.79 $960,130 - $1.33 Million	23,395 Added 985.47%	25,769 $1.38 Million
Q3 2020 Nov 13, 2020	BUY	$36.42 - $57.0 $29,136 - $45,600	800 Added 50.83%	2,374 $98,000
Q2 2020 Nov 02, 2020	BUY	$39.26 - $52.73 $61,795 - $82,997	1,574 New	1,574 $76,000
Q2 2020 Aug 14, 2020	SELL	$39.26 - $52.73 $70,707 - $94,966	-1,801 Closed	0 $0
Q1 2020 Nov 24, 2020	BUY	$31.65 - $46.87 $57,001 - $84,412	1,801 New	1,801 $74,000
Q4 2019 Feb 13, 2020	SELL	$36.21 - $51.4 $1.11 Million - $1.58 Million	-30,780 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$22.22 - $44.01 $683,931 - $1.35 Million	30,780 New	30,780 $1.11 Million
Q4 2018 Feb 14, 2019	SELL	$14.32 - $22.92 $247,134 - $395,553	-17,258 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$13.03 - $21.81 $224,871 - $376,396	17,258 New	17,258 $358,000
Q1 2018 May 15, 2018	SELL	$22.47 - $32.33 $1.99 Million - $2.86 Million	-88,500 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$26.84 - $39.14 $488,488 - $712,348	-18,200 Reduced 17.06%	88,500 $2.67 Million
Q3 2017 Nov 14, 2017	BUY	$29.49 - $38.37 $3.15 Million - $4.09 Million	106,700	106,700 $4.02 Million

Others Institutions Holding ACAD

# of Institutions

288

Shares Held

161M

Call Options Held

723K

Put Options Held

257K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.39B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account